To determine whether SIRT3 and SIRT6 are required for the growth of prostate cancer in vivo, we generated the LNCaP cell line with shRNA of SIRT3 and SIRT6 after doxycycline induction using a lentivirus transduction system. The gene discussed is SIRT6; the disease is prostate carcinoma.